Concepedia

Rachel Zangen

RZ

Statistics

Publications

5

Citations

413

H-Index

5

Active since

1998

Affiliations

Johns Hopkins University(Current)

Johns Hopkins Medicine

Rachel Zangen is an author at Johns Hopkins University specializing in medicine, cell biology, and molecular pharmacology.

Top concepts

MedicineCell BiologyHealthOncologyApoptosisCardiologyCell DeathPhysiologyPharmacologyHeart Failure

Publications per year

1998–2005

5

Publications

5

ΔNp63 induces β-catenin nuclear accumulation and signaling

Meera Patturajan, Shuji Nomoto, Matthias Sommer et al. · Cancer Cell · 2002 · 185 citations · Full text

Transcriptional Regulation, Signal Transduction, Signaling Pathway +6

RACK1 and Stratifin Target &Delta;Np63&alpha; for a Proteasome Degradation in Head and Neck Squamous Cell Carcinoma Cells upon DNA Damage

Alexey Fomenkov, Rachel Zangen, Yi‐Ping Huang et al. · Cell Cycle · 2004 · 99 citations · Full text

&Delta;Np63&alpha; Levels Correlate with Clinical Tumor Response to Cisplatin

Rachel Zangen, Edward A. Ratovitski, David Sidransky · Cell Cycle · 2005 · 79 citations

Proteasome Degradation, Apoptosis, Cell Death +17

Furosemide and digoxin inhibit thiamine uptake in cardiac cells

Abraham Zangen, Dror Botzer, Rachel Zangen et al. · European Journal of Pharmacology · 1998 · 35 citations

Molecular Pharmacology, Cardiomyopathy, Heart Failure +9

Molecular Analysis of Peritoneal Fluid in Ovarian Cancer Patients

Paola Parrella, Rachel Zangen, David Sidransky et al. · Modern Pathology · 2003 · 15 citations · Full text

Rows per page

1–5 of 5